The relationship between coronavirus disease 2019 (COVID-19) and cerebral blood flow (CBF) is not well understood. Here, we report on CBF measured by pseudo-continuous arterial spin labeling among adults that weeks prior had experienced flu-like symptoms with either a positive or negative COVID-19 diagnosis. Recruitment is ongoing, but at present we report no group differences in CBF across brain grey matter. However, subsequent regional analyses point to possible CBF abnormalities in those with a positive COVID-19 diagnosis.
This abstract and the presentation materials are available to members only; a login is required.